Protective efficacy of H7 subtype avian influenza DNA vaccine

Avian Diseases

Volumn 54, Issue SUPPL. 1, 2010, Pages 290-293

  Jiang, Yongping ^a   Zhang, Hongbo ^a   Wang, Guojun ^a   Zhang, Pingjing ^a   Tian, Guobin ^a   Bu, Zhigao ^a   Chen, Hualan ^a  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

Avian influenza virus; DNA vaccine; H7 subtype

Indexed keywords

DNA VACCINE; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

ANIMAL; AVIAN INFLUENZA; CHICKEN; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; GERMFREE ANIMAL; IMMUNOLOGY; PLASMID;

ANIMALS; CHICKENS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; PLASMIDS; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, DNA;

AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS;

EID: 77950209635     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8723-032409-ResNote.1     Document Type: Conference Paper

References (21)

1. Cherbonnel, M., J. Rousset, and V. Jestin. Strategies to improve protection against low-pathogenicity H7 avian influenza virus infection using DNA vaccines. Avian Dis. 47(3 Suppl): 1181-1186. 2003.
2. Fouchier, R. A., P. M. Schneeberger, F. W. Rozendaal, J. M. Broekman, S. A. Kemink, V. Munster, T. Kuiken, G. F. Rimmelzwaan, M. Schutten, G. J. Van Doornum, G. Koch, A. Bosman, M. Koopmans, and A. D. Osterhaus. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. U. S. A. 101(5):1356-1361. 2004.
3. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. U. S. A. 90(24):11478-11482. 1993.
4. Hirst, M., C. R. Astell, M. Griffith, S. M. Coughlin, M. Moksa, T. Zeng, D. E. Smailus, R. A. Holt, S. Jones, M. A. Marra, M. Petric, M. Krajden, D. Lawrence, A. Mak, R. Chow, D. M. Skowronski, S. A. Tweed, S. Goh, R. C. Brunham, J. Robinson, V. Bowes, K. Sojonky, S. K. Byrne, Y. Li, D. Kobasa, T. Booth, and M. Paetzel. Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg. Infect. Dis. 10(12):2192-2195. 2004.
5. Holm, L. Codon usage and gene expression. Nucleic Acids Res. 14(7):3075-3087. 1986.
6. Jiang, Y., K. Yu, H. Zhang, P. Zhang, C. Li, G. Tian, Y. Li, X. Wang, J. Ge, Z. Bu, and H. Chen. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res. 75(3):234-241. 2007.
7. Koopmans, M., B. Wilbrink, M. Conyn, G. Natrop, H. van der Nat, H. Vennema, A. Meijer, J. van Steenbergen, R. Fouchier, A. Osterhaus, and A. Bosman. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363(9409):587-593. 2004.
8. Larsen, D. L., and C. W. Olsen. Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs. Am. J. Vet. Res. 63(5):653-659. 2002.
9. Le Gall-Recule, G., M. Cherbonnel, N. Pelotte, P. Blanchard, Y. Morin, and V. Jestin. Importance of a prime-boost DNA/protein vaccination to protect chickens against low-pathogenic H7 avian influenza infection. Avian Dis. 51(1 Suppl):490-494. 2007.
10. Li, Y., C. Li, L. Liu, H. Wang, C. Wang, G. Tian, R. G. Webster, K. Yu, and H. Chen. Characterization of an avian influenza virus of subtype H7N2 isolated from chickens in northern China. Virus Genes 33:117-122. 2006.
11. Maines, T. R., L. M. Chen, Y. Matsuoka, H. Chen, T. Rowe, J. Ortin, A. Falcon, T. H. Nguyen, Q. Mai Le, E. R. Sedyaningsih, S. Harun, T. M. Tumpey, R. O. Donis, N. J. Cox, K. Subbarao, and J. M. Katz. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl. Acad. Sci. U. S. A. 103(32):12121-12126. 2006.
12. Nicholson, K. G., A. E. Colegate, A. Podda, I. Stephenson, J. Wood, E. Ypma, and M. C. Zambon. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357(9272):1937-1943. 2001.
13. OIE. Facts & figures, avian influenza [Internet]. Available from: http://www.oie.int/eng/en-index.htm
14. Robinson, H. L., L. A. Hunt, and R. G. Webster. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin expressing plasmid DNA. Vaccine 11(9):957-960. 1993.
15. Sakabe, S., Y. Sakoda, Y. Haraguchi, N. Isoda, K. Soda, H. Takakuwa, K. Saijo, A. Sawata, K. Kume, J. Hagiwara, K. Tuchiya, Z. Lin, R. Sakamoto, T. Imamura, T. Sasaki, N. Kokumai, Y. Kawaoka, and H. Kida. A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens. Vaccine 26(17):2127-2134. 2008.
16. Sambrook, J., F. E. F. Fritsh, and T. Maniatis. Molecular cloning-a laboratory manual, 2nd ed. Cold Spring Harbor Labortary Press. 1989.
17. Stephenson, I., K. G. Nicholson, J. M. Wood, M. C. Zambon, and J. M. Katz. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect. Dis. 4(8):499-509. 2004.
18. Suarez, D. L., and S. Schultz-Cherry. The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using as avian influenza model. Avian Dis. 44(4):861-868. 2000.
19. Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305(1):192-200. 2003.
20. Treanor, J. J., J. D. Campbell, K. M. Zangwill, T. Rowe, and M. Wolff. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N. Engl. J. Med. 354(13):1343-1351. 2006.
21. Tweed, S. A., D. M. Skowronski, S. T. David, A. Larder, M. Petric, W. Lees, Y. Li, J. Katz, M. Krajden, R. Tellier, C. Halpert, M. Hirst, C. Astell, D. Lawrence, and A. Mak. Human illness from avian influenza H7N3, British Columbia. Emerg. Infect. Dis. 10(12):2196-2199. 2004.